6 New Crown Vaccine in China are already in clinical trials

George Cooper / June 06,2020
6 New Crown Vaccine in China are already in clinical trials

         The latest data shows that as of May 31, 2020, the cumulative cure rate of confirmed cases of new coronary pneumonia in China is 94.3%. Of course, the final successful “war epidemic” also requires the landing and popularization of the new crown vaccine.
         Prior to the end of May, Zhong Nanshan also said that after the unremitting efforts of scientific and technological workers, my country is in the world’s first phalanx in vaccine research and development, and currently five vaccines have entered the second phase of clinical trials.
        6 New Crown Vaccine in China are already in clinical trials On June 6, Academician Zhong Nanshan mentioned in a live broadcast that after natural immunization requires 60-70% of people in a country to be infected, it will probably cause 30-40 million people to die, which is too expensive! Therefore, the solution still depends on large-scale vaccination. On May 30, the workshop of the Beijing Institute of Biological Products will be officially entered the final preparation stage before production after full disinfection. The new crown vaccine can be used as an emergency as early as this fall or the end of the year. Six vaccines in mainland China are already in clinical trials.
       “China Action Against New Coronary Pneumonia Outbreak” white paper released
        The white paper “China Action Against the New Coronary Pneumonia Epidemic” was released on the 7th. This document is called “an important document that truly records China’s hardship in the fight against epidemics.” The text is divided into two battlefields: China’s hardship in combating the epidemic, prevention, control and treatment. Fight, condense the powerful forces to fight the epidemic, and jointly build the four parts of the human health community.
   At the press conference held on the same day by China’s new office, Chinese Minister of Science and Technology Wang Zhigang said that all countries put the development of vaccines in a very important position to fight against new coronary pneumonia. When the vaccine is successfully developed and applied, China will “provide it as a public product to the world”.

Youtube URL: